# Bromocriptine mesylate

NDC: 0574-0106
Generic name: Bromocriptine mesylate
Labeler / Manufacturer: Padagis US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20140401

FDA application: ANDA077646

## Active ingredients

- BROMOCRIPTINE MESYLATE: 2.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0574-0106"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0574-0106
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ee2da00-faf8-4c51-a696-9462fa4f6050